Pancreatic Cancer Diagnoses and Mortality Rates Climb; Five-Year Survival Rate for Pancreatic Cancer Stalls at 13%

Jan 16, 2025

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for […]
READ MORE

The Pancreatic Cancer Action Network Welcomes Three New Members to Its Board of Directors and Announces New Chairs

Jul 11, 2024

LOS ANGELES, CALIF. – (JULY 11, 2024) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit in the fight […]
READ MORE

Lynn Matrisian, PhD, MBA, chief science officer at the Pancreatic Cancer Action Network (PanCAN)

PanCAN’s Chief Science Officer Elected as AAAS Fellow for Biological Sciences

Apr 22, 2024

In honor of her distinguished contributions to the field of cancer biology, Lynn Matrisian, PhD, MBA, chief science officer at […]
READ MORE

Anna Berkenblit, MD, MMSc

The Pancreatic Cancer Action Network Names Anna Berkenblit, MD, MMSc As First-Ever Chief Scientific and Medical Officer

Apr 2, 2024

LOS ANGELES, CALIF. – (APRIL 2, 2024) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit in the fight […]
READ MORE

Statement from the Pancreatic Cancer Action Network (PanCAN) in Response to President Biden’s State of the Union Speech and Commitment to Fighting Cancer

Mar 8, 2024

The Pancreatic Cancer Action Network (PanCAN) applauds the Biden administration for its steadfast commitment to ending cancer as we know […]
READ MORE

Statement from the Pancreatic Cancer Action Network on U.S. FDA Approval of NALIRIFOX 

Feb 13, 2024

The Pancreatic Cancer Action Network (PanCAN), a leading patient advocacy organization dedicated to fighting the world’s toughest cancer, released a […]
READ MORE

Five-Year Survival Rate for Pancreatic Cancer Increased to 13% Signaling More Progress and More Hope for Patients

Jan 17, 2024

Despite advances in pancreatic cancer the disease is on track to become the second-leading cause of cancer-related deaths before 2030 […]
READ MORE